Business Segments

Drug Discovery & Development Solutions

Jubilant Biosys Limited is a part of the Jubilant Life Sciences family of companies with R&D centers in India and business offices in Asia and North America. With our global reach, Jubilant Biosys provides comprehensive drug discovery services and contract research services – from target discovery to candidate selection and with flexible business models (FFS, FTE and risk shared) – in partnership with leading worldwide healthcare companies.

A Leading Pre-Clinical Contract Research Organisation

With a clear scientific focus in oncology, metabolic disorders, central nervous system (CNS) diseases, pain and inflammation, Jubilant Biosys has rapidly emerged as a leading collaborator for pharmaceutical and biotechnology companies worldwide. In each of these therapeutic areas, Jubilant Biosys has developed a deep level of expertise in discovery informatics, computational chemistry, medicinal chemistry, structural biology, biology, in vivo, in vitro models and translational sciences. Combined with strong clinical development and manufacturing capabilities from other Jubilant subsidiaries, Jubilant Biosys has risen as a fully integrated contract research organization in India and headquartered at Bengaluru with end-to-end solutions.

Our ability to be the preferred collaborator in the drug discovery domain is sustained by our commitment to comply with and continually improve our quality systems and to provide the following services:

  • Contract Research
  • Pre-clinical CRO
  • Drug Discovery
  • Virtual Screening
  • Protein Crystallization
  • Toxicology
  • In Vitro ADME
  • Medicinal Chemistry

Jubilant Biosys collaborates with the world’s leading pharmaceutical, biotech companies, academic institutions and research foundations.

Why Jubilant Biosys?

  • A highly experienced scientific team that has delivered >75 integrated discovery programs
  • New technologies applied to accelerate drug discovery and improve decision-making quality
  • A boutique CRO with a talented team of >550 scientists giving your program priority
  • Investing in the future of drug discovery and development through expansion
  • Leadership with a global pedigree in the US, EU and Japan

Innovative and rigorous science, excellence in execution, and absolute integrity combined with flexible business models have enabled Jubilant Biosys to deliver valuable outcomes in a relatively short time. The hallmark of Jubilant Biosys’s collaborative model is the creation of value to their partners.

The Jubilant Advantage

  • Part of a large and stable organization with major investments in Life Sciences
  • A track-record of successful outcomes to large pharmaceuticals, mid-size biotechs & virtual companies on over 60 integrated programs (3 INDs and 5 Candidates)
  • Commitment to Innovation through investments in own platform and assets to partner with our clients
  • Flexible business models including risk share on integrated projects (38 discovery milestones achieved to date)
  • Many long term collaborations (FFS, FTE and integrated) due to consistent and quality delivery
  • IND enabling capabilities including GMP & GLP toxicology.
  • Single integrated site augmented by additional chemistry capacity.

Jubilant Biosys collaborates with the world’s leading pharmaceutical, biotech companies, academic institutions and research foundations.